Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma A Ligresti, AS Moriello, K Starowicz, I Matias, S Pisanti, L De Petrocellis, ... Journal of Pharmacology and Experimental Therapeutics 318 (3), 1375-1387, 2006 | 702 | 2006 |
Cannabidiol: State of the art and new challenges for therapeutic applications S Pisanti, AM Malfitano, E Ciaglia, A Lamberti, R Ranieri, G Cuomo, ... Pharmacology & therapeutics 175, 133-150, 2017 | 615 | 2017 |
Pharmacological actions of statins: a critical appraisal in the management of cancer P Gazzerro, MC Proto, G Gangemi, AM Malfitano, E Ciaglia, S Pisanti, ... Pharmacological reviews 64 (1), 102-146, 2012 | 548 | 2012 |
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation L De Petrocellis, D Melck, A Palmisano, T Bisogno, C Laezza, M Bifulco, ... Proceedings of the National Academy of Sciences 95 (14), 8375-8380, 1998 | 545 | 1998 |
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation D Melck, L De Petrocellis, P Orlando, T Bisogno, C Laezza, M Bifulco, ... Endocrinology 141 (1), 118-126, 2000 | 312 | 2000 |
Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis G Portella, C Laezza, P Laccetti, L De Petrocellis, V Di Marzo, M Bifulco The FASEB Journal 17 (12), 1771-1773, 2003 | 246 | 2003 |
The endocannabinoid signaling system in cancer S Pisanti, P Picardi, A D’Alessandro, C Laezza, M Bifulco Trends in pharmacological sciences 34 (5), 273-282, 2013 | 233 | 2013 |
Cannabinoids and cancer: pros and cons of an antitumour strategy M Bifulco, C Laezza, S Pisanti, P Gazzerro British journal of pharmacology 148 (2), 123-135, 2006 | 212 | 2006 |
Anandamide inhibits adhesion and migration of breast cancer cells C Grimaldi, S Pisanti, C Laezza, AM Malfitano, A Santoro, M Vitale, ... Experimental cell research 312 (4), 363-373, 2006 | 203 | 2006 |
2′, 3′-Cyclic nucleotide 3′-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin M Bifulco, C Laezza, S Stingo, J Wolff Proceedings of the National Academy of Sciences 99 (4), 1807-1812, 2002 | 178 | 2002 |
Control by the endogenous cannabinoid system of ras oncogene‐dependent tumor growth M Bifulco, C Laezza, G Portella, M Vitale, P Orlando, L De Petrocellis, ... The FASEB Journal 15 (14), 1-17, 2001 | 175 | 2001 |
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation M Bifulco, C Laezza, M Valenti, A Ligresti, G Portella, V Di Marzo The FASEB journal 18 (13), 1606-1608, 2004 | 162 | 2004 |
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism D Sarnataro, S Pisanti, A Santoro, P Gazzerro, AM Malfitano, C Laezza, ... Molecular pharmacology 70 (4), 1298-1306, 2006 | 140 | 2006 |
Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor‐suppressor efficacy S Pisanti, C Borselli, O Oliviero, C Laezza, P Gazzerro, M Bifulco Journal of cellular physiology 211 (2), 495-503, 2007 | 129 | 2007 |
The endocannabinoid system: A target for cancer treatment C Laezza, C Pagano, G Navarra, O Pastorino, MC Proto, D Fiore, ... International journal of molecular sciences 21 (3), 747, 2020 | 124 | 2020 |
The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase I Esposito, MC Proto, P Gazzerro, C Laezza, C Miele, AT Alberobello, ... Molecular pharmacology 74 (6), 1678-1686, 2008 | 114 | 2008 |
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents S Pisanti, AM Malfitano, C Grimaldi, A Santoro, P Gazzerro, C Laezza, ... Best Practice & Research Clinical Endocrinology & Metabolism 23 (1), 117-131, 2009 | 111 | 2009 |
Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells C Laezza, S Pisanti, E Crescenzi, M Bifulco FEBS letters 580 (26), 6076-6082, 2006 | 107 | 2006 |
Cannabinoids: therapeutic use in clinical practice C Pagano, G Navarra, L Coppola, G Avilia, M Bifulco, C Laezza International journal of molecular sciences 23 (6), 3344, 2022 | 106 | 2022 |
Update on the endocannabinoid system as an anticancer target AM Malfitano, E Ciaglia, G Gangemi, P Gazzerro, C Laezza, M Bifulco Expert opinion on therapeutic targets 15 (3), 297-308, 2011 | 105 | 2011 |